Key result
Recombinant CHI3L1 administration worsened ventricular remodeling after myocardial infarction in mice, whereas CHI3L1 deficiency reduced remodeling and accelerated the resolution of inflammation.
Why the study?
Clinical studies linked chitinase-3 like-1 to MI outcomes, but the role of this neutrophil-derived factor in post-MI remodeling was not fully understood.
Does CHI3L1 exacerbate ventricular remodeling and inflammation after myocardial infarction in mice?
Does CHI3L1 exacerbate ventricular remodeling and inflammation after myocardial infarction in mice?
Neutrophil-secreted CHI3L1 exacerbates ventricular inflammation and remodeling after myocardial infarction, highlighting a potential new therapeutic target for post-MI heart failure.
Answers are grounded in this paper and cite their sources.
CHI3L1 upregulation and neutrophil secretion post-MI does not directly affect remodeling in animals; leaves open its biomarker or therapeutic role in patients.
Myocardial infarction (MI) triggers acute inflammation, marked by neutrophil infiltration. Although neutrophils are central to this response, the exact role of various neutrophil-derived factors is not fully understood. Clinical studies have linked one such enigmatic factor, chitinase-3 like-1, to MI outcomes. Hence, we investigated its role in post-MI remodeling. We found that chitinase-3 like-1 (CHI3L1) is upregulated after MI and secreted by activated neutrophils but does not directly affect neutrophil activity. To assess whether increased CHI3L1 influences ventricular remodeling, we subjected mice to non-reperfused MI and administered recombinant CHI3L1. Increased CHI3L1 levels worsened ventricular remodeling. In contrast, CHI3L1-deficient mice showed reduced ventricular remodeling after MI. To explore the underlying mechanisms, we assessed interactions with other cells known to be important in ventricular remodeling. Immunoprofiling of infarcted CHI3L1-deficient mouse hearts revealed a faster decline in neutrophil and monocyte numbers, indicating quicker resolution of inflammation. These findings provide direct evidence that CHI3L1 exacerbates ventricular inflammation and remodeling following MI through gain- and loss-of-function approaches.
No takes yet. Share an insight, caveat, or question.
Stephan et al. (2025) studied Myocardial infarction. Recombinant CHI3L1 / CHI3L1 deficiency was evaluated on Ventricular remodeling and inflammation. Recombinant CHI3L1 administration worsened ventricular remodeling after myocardial infarction in mice, whereas CHI3L1 deficiency reduced remodeling and accelerated the resolution of inflammation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: